Colonic drug delivery. I - The colon as a site for drug delivery;Liberação específica de fármacos para administração no cólon por via oral. I - O cólon como local de liberação de fármacos

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 42, Issue 3, 2006, Pages 319-335

  Freire, Ana Cristina ^a   Podczeck, Fridrun ^b   Sousa, João ^a   Veiga, Francisco ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

Absorption; Colon; Colonic microflora; Colonic pH; Gastrointestinal transit; Inflammatory bowel disease

Indexed keywords

EUDRAGIT; MESALAZINE; PEPTIDASE; PEPTIDE DERIVATIVE; PROTEIN DERIVATIVE;

COLON ABSORPTION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; ENTERITIS; ENZYME ACTIVITY; HUMAN; INTESTINE TRANSIT TIME; PH MEASUREMENT; REVIEW;

EID: 33845488123     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-93322006000300003     Document Type: Review

References (77)

1. ABRAHAMSSON, B.; ALPSTEN, M.; JONSSON, U. E.; LUNDBERG, P. J.; SANDBERG, A.; SUNDGREN, M.; SVENHEDEN, A.; TOLLI, J. Gastro-intestinal transit of a multiple-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon. Int. J. Pharm., Amsterdam, v. 140, p. 229-235, 1996.
2. ADKIN, D.A.; DAVIS, S.S.; SPARROW, R. A.; WILDING, I.R. Colonic transit of different sized tablets in healthy subjects. J. Control. Release, Amsterdam, v. 23, p. 147-156, 1993.
3. ASHFORD, M.; FELL, J. T. Targeting drugs to the colon: delivery systems for oral administration. J. Drug Targeting, London, v. 2, p. 241-258, 1994.
4. BECHGAARD, H.; CHRISTENSEN, F. N.; DAVIS, S. S.; HARDY, J. G.; TAYLORS, M. J.; WHALLEY, D. R.; WILSON, C. G. Gastrointestinal transit of pellets systems in ileostomy subjects and the effect of density. J. Pharm. Pharmacol., London, v. 37, p. 718-721, 1985.
5. BORIN, M. T.; KHARE, S.; BEIHN, R. M.; JAY, M. The effect of food on gastrointestinal transit (GI) transit of sustained-release ibuprofen tablets as evaluated by gamma scintigraphy. Pharma. Res., Amsterdam, v. 7, n.3, p.304-307, 1990.
6. BOTH, H.; TORP-PEDERSEN, K.; KREINER, S.; HENDRIKSEN, B., V. Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group. Scand. J. Gastroenterol., London, v. 18, p. 987-991, 1983.
7. CANVA-DELCAMBRE, V.; SOENEN, A.; MIZON, A.; CORTOT, J.; MIZON, J.; COLOMBEL, J.F. L'activite beta-galactosidaseique fecale est diminuee a cours de la maladie de Crohn. Gastroenterol. Clin. Sci., Paris, v. 17, p. 718-722, 1993.
8. CLARKE, G. M.; NEWTON, J. M.; SHORT, M. B. Comparative gastrointestinal transit of pellets systems of varying density. Int. J. Pharm., Amsterdam, v. 114, p. 1-11, 1995.
9. CLARKE, G. M.; NEWTON, J. M.; SHORT, M. B. Gastrointestinal transit of pellets of differing size and density. Int. J. Pharm., Amsterdam, v. 100, p. 81-95, 1993.
10. CHRISTIAN, P. E.; MOORE, J. G.; SORENSON, J. A.; COLEMAN, R. E.; WELCH, D. M. Effects of meal size and correction technique on gastric emptying time: studies with two tracers and opposed detectors. J. Nucl. Med., London, v. 21, p. 883-885, 1980.
11. rd Ed, Year Book Medical Publisher, New York, 1971.
12. DAVID, A.; YAGEN, B.; SINTOV, A.; RUBINSTEIN, A. Acrylic polymers for colon-specific drug delivery. STP Pharma Sci., Paris, v. 7. n. 6, p. 546-554, 1997.
13. DAVIS, S. S.; HARDY, J. G.; FARA, J. W. Transit of pharmaceutical dosage forms through the small intestine. Gut, London, v. 27, p. 886-892, 1986.
14. DAVIS, S. S. Small intestine transit. In: HARDY. J. G.; DAVIS, S. S.; WILSON, C. G., eds. Drug delivery to the gastrointestinal tract. New York: Ellis Horwood Limited. 1989. p.49-61.
15. DEVEROUX, J. E.; NEWTON, J. M.; SHORT, M. B. The influence of density on the gastrointestinal transit of pellets. J. Pharm. Pharmacol., London, v. 42, p. 500-501, 1990.
16. DODDA-KASHI, S.; GRASS, G.M.; RUBAS, W. Oral route of peptide and protein delivery. In: LEE, V.H.L., ed. Peptide and protein drug delivery. New York: Marcel-Dekker, 1991. p.691-738.
17. EDWARDS, C. A. Anatomical and physiological basis: physiological factors influencing drug absorption. In: BIECK, P. R., ed. Colonic drug absorption and metabolism. Drugs and the Pharmaceutical Sciences, New York: Marcel-Dekker, v. 60, 1993. p. 1-28.
18. ENCK, P.; MERLIN, V.; ERCKENBRECHT, J.F.; WIENBECK, M. Stress effects on gastrointestinal transit in the rat. Gut. London, v. 30, p. 455-459, 1989.
19. EMBDEN, J.G.H.R.; VAN LIESHOUT, L.M.C. Increased fecal glycosidases in patients with Crohn's disease. Digestion, London, v. 37, p. 43-50, 1987.
20. EVANS, D. F.; PYE, G.; BRAMLEY, R.; CLARK, A. G.; DYSON, T. J., HARDCASTLE, J. D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. London, v. 29, p. 1035-1041, 1988.
21. FAIGLE, J. W. Drug Metabolism in the Colon Wall and Lumen. In: BIECK, P. R., ed. Colonic drug absorption and metabolism. Drugs and the Pharmaceutical Sciences, New York: Marcel-Dekker, v. 60, 1993, p. 29-54.
22. FALLINGBORG, J.; CHRISTENSEN, L. A.; JACOBSEN, B. A.; RASMUSSEN, S.N. Very low intraluminal colonic pH in patients with active ulcerative colitis. Dig. Dix. Sci., London, v. 38, n. 11, p. 1989-1993, 1993.
23. FOLLONIER, N.; DOELKER, E. Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. S.T.P. Pharma Sci., Paris, v. 2, p. 141-158, 1992.
24. FRIEND, D. R. New oral delivery systems for treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev., Amsterdam, v. 57, p. 247-265, 2004.
25. GEAR, J.S.S.; BRODIBB, A. J. M.; WARE, A.; MANNY, I. Fiber and bowel transit times. Brit. J. Nutr., London, v.45, p. 77-82, 1981.
26. GOTO, T.; TANIDA, N.; YOSHINAGA, T.; SATO, S.; BALL, D.J.; WILDING, I.R.; KOBAYASHI, E.; FUJIMURA, A. Pharmaceutical design of a novel colon-target delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans. J. Control. Release, Amsterdam, v. 97, p. 31-42, 2004.
27. GUPTA, V. K.; ASSMUS, M. W.; BECKERT, T. E.; PRICE, J. C. A novel pH- and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables. Int. J. Pharm., Amsterdam, v. 213, p. 93-102, 2001.
28. HAEBERLIN, B.; FRIEND, D. R. Anatomy and physiology of the gastrointestinal tract: implications for colonic drug delivery. In: FRIEND, D. R. ed. Oral colon-specific drug delivery, London, CRC Press, 1992. p. 1-43.
29. HARDY, J. G. Colonic Transit and Drug Delivery. In: HARDY, J. G.; DAVIS, S. S.; WILSON, C. G., eds. Drug delivery: to the gastrointestinal tract. Ed. New York: Ellis Horwood Limited. 1989. p.75-81.
30. HARDY, J. G. Scintigraphic Tecniques in Studying Colonic Drug Absorption. In: BIECK, P. R., ed. Colonic drug absorption and metabolism, Drugs and the Pharmaceutical Sciences. Ed. New York: Marcel-Dekker, v. 60, 1993, p. 77-87.
31. HARDY, J. G.; DAVIS, S. S.; KHOSLA, R.; ROBERTSON, C. S. Gastrointestinal transit of small tablets in patients with ulcerative colitis. Int. J. Pharm., Amsterdam, v. 48, p. 79-82, 1988.
32. HARDY, J. G.; WILSON, C. G.; WOOD, E. Drug delivery to the proximal colon. J. Pharm. Pharmacol., London, v. 37, p. 874-877, 1985.
33. KHAN, M. Z. I.; PREBEG Z.; KURJAKOVIC, N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers I. Manipulation of drug release using Eudragit® L100-55 and Eudragit® S100 combinations. J. Control. Release, Amsterdam, v. 58, p. 215-222, 1999.
34. KLOTZ, U.; SCHWAB, M. Topical delivery of therapeutics agents in the treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev., Amsterdam, v. 57, p. 267-279, 2004.
35. KYROUDIS, A.; MARKANTONIS, S. L.; BECKETT, A. H. The effect of food on the movement of pellets in the gastrointestinal tract. Pharm. Weekbl. Scien. Ed., Amsterdam, v. 11, p. 44-49, 1988.
36. LAURSEN, L. S.; STOKHOLM, M.; BUKHAVE, K.; RASK-MADSEN, J.; LAURITSEN, K. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. Gut, London, v. 31, p. 1271-1276, 1990.
37. MACLEOD, A. D.; TOZER, T. N. Kinetic perspectives in colon drug delivery. In: FRIEND, D. R. ed. Oral colon-specific drug delivery, London, CRC Press, 1992. p. 85-114.
38. MARDINI, H. A. L.; LINDSAY, D. C.; DEIGHTON, C. M.; RECORD, C. O. Effect of polymer coating on fecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis. Gut, London, v. 28, p. 1084-1089, 1987.
39. METCALF, A. M.; PHILLIPS, S. F.; ZINSMEISTER, A. R.; MCCARTY, R. L.; BEART, R. W.; WOLFF, B.G. Simplified assessment of segmentai colonic transit. Gastroenterology, London, v. 92, p. 40-47, 1987.
40. MRSNY, R. J., Drug absorption in the colon: a critical review. In: FRIEND, D. R. ed. Oral-colon specific drug delivery, London: CRC Press, 1992a. p. 45-84.
41. MRSNY, R. J. The colon as a site for drug delivery. J. Control. Release, Amsterdam, v. 22, p. 15-34, 1992b.
42. NUGENT, S. G.; RAMPTON, D. S.; EVANS, D. F. Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut, London, v. 48, p. 571-577, 2001.
43. O'REILLY, S.; WILSON, C. G.; HARDY, J. G.; The influence of food on the gastric emptying of multiparticulate dosage forms. Int. J. Pharm., Amsterdam, v. 34, p. 213-216, 1987.
44. OTT, S. J.; MUSFELDT, M.; WENDEROTH, D.F.; HAMPE, J.; BRANT, O.; FÖLSH, U. R.; TIMMIS, K. N.; SCHREIBER, S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut, London, v. 53, p. 685-693, 2003.
45. PHILLIPS, S. F.; QUIGLEY, E.M.M.; KUMAR, D.; KAMATH, P.S. Motility of the ileocecal junction. Gut, London, v.29, p.390-406, 1988.
46. PRICE, J. M. C.; DAVIS, S. S.; SPARROW, R. A.; WILDING, I. R. The effect of meal composition on the gastro colonic response: implications for drug delivery to the colon. Pharm. Res., Stuttgart, v. 10, n. 5, p. 722-726, 1993.
47. PYE, G.; CROMPTON, J.; EVANS, D. Effect of dietary fibre on colonic pH in healthy volunteers. Gut, London, v. 28: A:1366, 1987.
48. QUIGLEY, E. M. M.; BORODY, T. J.; PHILIPS, S. F.; WIENBECK, M. T. R. L.; HADDAD, A. Motility of the terminal ileum and ileo-cecal junction in healthy humans. Gastroenterology, London, v. 87, p. 857-866, 1984.
49. READ, N. W.; MANGNALL, Y. F.; TOMLIN, J.; BROWN, N. Non-Invasive Methods for Measuring Gastrointestinal Transit. In: HARDY, J. G.; DAVIS, S. S.; WILSON, C. G., ed. Drug delivery to the gastrointestinal tract. New York: Ellis Horwood Limited. 1989, p.9-25.
50. RILEY, S.A. Influence of Disease on Colonic Drug Absorption. In: BIECK, P. R., (Ed,). Colonic drug absorption and metabolism. Drugs and the Pharmaceutical Sciences, New York: Marcel-Dekker, v. 60, 1993. p. 177-195.
51. ROEDIGER, W. E. The colonic epithelium in ulcerative colitis: an energy deficiency disease? Lancet, London, v. 2, p. 712-715, 1980.
52. ROUGE, N.; BURI, P.; DOELKER, E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm., Amsterdam v. 136, p. 117-139, 1996.
53. RUBINSTEIN, A.; SINTOV, A. Biodegradable polymeric matrices with the potential specificity to the large intestine. In: FRIEND, D. R. ed. Oral colon-specific drug delivery, London, CRC Press, 1992. p. 233-257.
54. RUBINSTEIN, A.; TIROSH, B.; BALUOM, M.; NASSAR, T.; DAVID, A.; RADAI, R.; GLIKO-KABIR, I.; FRIEDMAN, M. The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools. J. Control. Release, Amsterdam, v.46, p. 59-73, 1997.
55. SAFFRAN, M. Oral colon-specific drug delivery with emphasis in insulin. In: FRIEND. D. R. ed. Oral colon-specific drug delivery, London, CRC Press, 1992. p. 115-142.
56. SANGALLI, M. E.; MARONI, A.; ZEMA, L.; GIORDANO, F.; GAZZANIGA, A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J. Control. Release, Amsterdam, v. 73, p. 103-110, 2001.
57. SASAKI, Y.; HADA, R.; NAKAJIMA, H.; FUKUDA, S.; MUNAKATA, A. Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: Colonic luminal pH in normal subjects and in patients with Cohn's disease. Am. J. Gastroenterology. London, v. 92, p. 114-118, 1997.
58. SAWADA, T.; KONDO, H.; NAKASHIMA, H.; SAKO, K.; HAYASHI, M. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy. Int. J. Pharm., Amsterdam, v. 280, p. 103-111, 2004.
59. SCHROEDER, K. W.; TREMAINE, W. J.; ILSTRUP, D. M. Coated 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. New Eng. J. Med., London, v. 317, p. 1625-1629, 1987
60. SICCARDI, D.; TURNER, J. R.; MRSNY, R. Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease. Adv. Drug Deliv. Rev., Amsterdam, v.57, p. 219-235, 2005.
61. SINHA, S. R.; KUMRIA, R. Binders for colon specific drug delivery: an in vitro evaluation. Int. J. Pharm., Amsterdam, v. 249, p. 23-31, 2002.
62. SPILLER, R. C.; BROWN, M.L. AND PHILLIPS, S. F. Emptying of terminal ileum in intact humans- Influence of meal residue and ileum motility. Gastroenterology, London, v. 92, p. 724-779, 1987.
63. STEED, K. P.; HOOPER, G.; VENTURA, P.; MUSA, R.; WILDING, I. R. The in vivo behaviour of a colonic delivery system: a pilot study in man. Int. J. Pharm., Amsterdam, v. 112, p. 199-206, 1994.
64. STEED, K. P.; WILSON, C. G.; WASHINGTON, N. Drug delivery to the large intestine. In: WILSON, G.; WASHINGTON, N. eds. Physiological pharmaceutics: Biological Barriers to drug absorption. London: Ellis Horwood Limited. 1989. p.91-108.
65. SUGITO, K.; OGATA, H.; GOTO, H.; KANIWA, N.; TAKAHATA, H.; SAMEJIMA, M. Gastric emptying rate of drug preparations. III. Effects of size of enteric micro-capsules with mean diameters ranging from 0.1 to 1.1 mm in man. Chem. Pharm. Bull., London, v. 40, p. 3343-3345, 1992.
66. TAYLOR, D. C.; LYNCH, J.; LEAHY, D. E. Models for intestinal permeability to drugs. In: HARDY, J. G.; DAVIS, S. S.; WILSON, C. G., ed. Drug delivery to the gastrointestinal tract. New York: Ellis Horwood Limited. 1989. p. 133-146.
67. TOMITA, M.; SHIGA, M.; HAYASHI, M.; AWAZU, S. Enhancement of colonic drug absorption by the paracellular permeation route. Pharm. Res., Amsterdam, v. 5, n. 6, p. 341-346, 1988.
68. TULEO, C.; ANDRIEUX, C.; BOY, P.; CHAUMEIL, P. C. Gastrointestinal transit of pellets in rats: effect of size and density, Int. J. Pharm., Amsterdam, v. 180, p. 123-131, 1999.
69. VANDAMME, Th.F.; LENOURRY, A.; CHARRUEAU, C.; CHAUMEIL, J-C. The use of polysaccharides to target drugs to the colon. Carbohydrates Polymers, Amsterdam, v.48, p.219-231, 2001.
70. VAN DER BIJL, P.; VAN EYK, A.D.; Comparative in vitro permeability of human vaginal, small intestinal and colonic mucosa, Int. J. Pharm. Amsterdam, v.261, p. 147-152, 2003.
71. VAN DER MOOTER, G.; KINGET, R. Oral-colon-specific drug delivery: a review, Drug delivery, London, v. 2, p. 81-93, 1995.
72. VERNIA, P.; CAPRILLI, R.; LATELLA, G.; BARBETTI, F.; MAGLIOCCA, F. M.; CITTADINI, M. Fecal lactate and ulcerative colitis, Gastroenterology, London, v. 95, p. 1564-1568, 1988.
73. WATTS, P. J.; ILLUM, L. Colonic drug delivery. Drug Dev. Ind. Pharm., London, v. 23, p. 893-913, 1997.
74. WILDING I. R. Scintigraphic evaluation of colonic delivery systems. S.T.P. Pharma Sci., Paris, v.5, n. 1, p. 13-18, 1995.
75. WRONG, O.; EDMONDS, C.; CHADWICK, V. The large intestine: its role in mammalian nutrition and homeostasis. Lancaster UK:MTP Press, London, p. 133-155, 1981.
76. YAMNI, J.; MIZON, C.; CAPON, C.; COLOMBEL, J.F.; FOURNET, B.; CORTOT, A.; MIZON, J. Decreased fecal exoglycosidase activities identify a subset of patients with active Crohn's disease. Digestion, London, v. 83, p. 409-415, 1992.
77. YANG, L.; CHU, J. S.; FIX, J. A.; Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation, Int. J. Pharm., Amsterdam, v. 235, p. 1-15, 2002.